Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
Clinical trial NCT06772064 · RECRUITING
Trial details
- NCT number
- NCT06772064
- Sponsor
- Xiuli Zuo
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2025-12-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.